Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone
Article in Neuropharmacology (January 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone
Preprint in bioRxiv (September 2023)
Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review
Article in Frontiers in Psychiatry (June 2023)